The Bone, Exercise, Alendronate, and Caloric Restriction (BEACON) trial design and methods
Contemporary Clinical Trials · 2024
DOI: 10.1016/j.cct.2024.107692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Kristen M Beavers und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, USA. Electronic address: beaverkm@wfu.edu. Hauptthemen laut MEDLINE: Alendronate, Bone Density, Bone Density Conservation Agents, Caloric Restriction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Among older adults living with obesity, intentional weight loss (WL) improves prognosis of many comorbidities. However, concomitant decline in bone mineral density (BMD) limits overall benefit of WL by increasing osteoporotic fracture risk. Identification of intervention strategies to maximize body fat loss, while minimizing harm to the musculoskeletal system, is an important area of clinical research. The main objective of the Bone, Exercise, Alendronate, and Caloric Restriction (BEACON) trial (NCT05764733) is to compare the independent and combined effects of a 12-month intervention of resistance training (RT) plus bone-loading exercises and bisphosphonate use on dietary WL-associated bone loss among 308 older (≥60 years) adults living with an indication for WL and bisphosphonate use. METHODS: All participants will receive the same group-mediated dietary intervention targeting 8-10 % WL and be randomized to one of four groups: no RT and placebo capsules (NoRT+PL); progressive RT plus bone-loading exercises and placebo capsules (RT++PL); no RT and oral bisphosphonate (70 mg weekly oral alendronate; NoRT+BIS); or progressive RT plus bone-loading exercises and oral bisphosphonate (RT++BIS). Total hip areal (a)BMD measured via dual-energy x-ray absorptiometry (DXA) is the primary, powered study outcome. Secondary skeletal outcome measures include femoral neck and lumbar spine aBMD, high resolution peripheral quantitative computed tomography (HRpQCT) bone assessments of the radius and tibia, and biomarkers of bone turnover. DISCUSSION: BEACON will address an understudied, yet important, clinical research question by studying the independent and combined effects of two scalable intervention strategies aimed at optimizing skeletal integrity in older adults undergoing WL. CLINICAL TRIALS REGISTRATION: NCT05764733.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, USA. Electronic address: beaverkm@wfu.edu.
- Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, USA.
- Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Statistical Sciences, Wake Forest University, Winston-Salem, NC, USA.
- Division of Geriatric Medicine, University of Colorado Anschutz Medical Campus, USA.
- Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Förderung
- NIA NIH HHS
- NIH HHS
- NCATS NIH HHS
- NIAMS NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- National Institute on Aging
- National Institutes of Health
Zitieren
APA
Beavers, K. M., Wolle, B. R., Ard, J. D., Beavers, D. P., Biehl, O., Brubaker, P. H., Burghardt, A. J., Calderone, C. T., Carballido-Gamio, J., Fanning, J., Kohrt, W. M., Love, M., MacLean, C. M., Nicklas, B. J., Stapleton, J., Swanson, C. M., Weaver, A. A., Worden, M., & Wherry, S. J. (2024). The Bone, Exercise, Alendronate, and Caloric Restriction (BEACON) trial design and methods. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107692
Vancouver
Beavers KM, Wolle BR, Ard JD, Beavers DP, Biehl O, Brubaker PH, et al. The Bone, Exercise, Alendronate, and Caloric Restriction (BEACON) trial design and methods. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107692
BibTeX
@article{Beavers2024,
author = {Beavers, Kristen M and Wolle, Brianna R and Ard, Jamy D and Beavers, Daniel P and Biehl, Olivia and Brubaker, Peter H and Burghardt, Andrew J and Calderone, Christa T and Carballido-Gamio, Julio and Fanning, Jason and Kohrt, Wendy M and Love, Monica and MacLean, Catherine M and Nicklas, Barbara J and Stapleton, Joshua and Swanson, Christine M and Weaver, Ashley A and Worden, Marcelina and Wherry, Sarah J},
title = {The Bone, Exercise, Alendronate, and Caloric Restriction (BEACON) trial design and methods},
journal = {Contemporary Clinical Trials},
year = {2024},
doi = {10.1016/j.cct.2024.107692}
}
EUVIMED